Tagrisso (osimertinib)

pCPA File Number: 21092

Negotiation Status:

Concluded with an LOI

Indication(s):

Non-Small Cell Lung Cancer (First-line, locally advanced or metastatic)

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

PC0137-000

pCPA Engagement Letter Issued:

2019-03-14

Negotiation Process Concluded:

2019-11-19